TREA

Steven David Knight

Follow

Person

  • Collegeville, PA, US
People

Patents Grantslast 30 patents

  • Information Patent Grant

    Enhancer of zeste homolog 2 inhibitors
    • Patent number 10,604,531
    • Issue date Mar 31, 2020
    • GlaxoSmithKline Intellectual Property (No. 2) Limited
    • Steven David Knight
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Enhancer of zeste homolog 2 inhibitors
    • Patent number 9,956,210
    • Issue date May 1, 2018
    • GlaxoSmithKline LLC
    • Joelle Lorraine Burgess
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Enhancer of zeste homolog 2 inhibitors
    • Patent number 9,790,212
    • Issue date Oct 17, 2017
    • GlaxoSmithKline Intellectual Property (No. 2) Limited
    • Charles William Blackledge
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Enhancer of zeste homolog 2 inhibitors
    • Patent number 9,562,041
    • Issue date Feb 7, 2017
    • GlaxoSmithKline LLC
    • Joelle Lorraine Burgess
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Enhancer of zeste homolog 2 inhibitors
    • Patent number 9,556,157
    • Issue date Jan 31, 2017
    • GlaxoSmithKline Intellectual Property (No. 2) Limited
    • Joelle Lorraine Burgess
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Enhancer of zeste homolog 2 inhibitors
    • Patent number 9,505,745
    • Issue date Nov 29, 2016
    • GlaxoSmithKline Intellectual Property (No. 2) Limited
    • Charles William Blackledge
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Indoles
    • Patent number 9,402,836
    • Issue date Aug 2, 2016
    • GlaxoSmithKline LLC
    • James Brackley
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Enhancer of Zeste Homolog 2 inhibitors
    • Patent number 9,382,234
    • Issue date Jul 5, 2016
    • GlaxoSmithKline LLC
    • Steven David Knight
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Azaindazoles
    • Patent number 9,073,924
    • Issue date Jul 7, 2015
    • GlaxoSmithKline LLC
    • Joelle Lorraine Burgess
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Indazoles
    • Patent number 9,018,382
    • Issue date Apr 28, 2015
    • GlaxoSmithKline LLC
    • Celine Duquenne
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Indoles
    • Patent number 8,975,291
    • Issue date Mar 10, 2015
    • GlaxoSmithKline LLC
    • James Brackley
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Indazoles
    • Patent number 8,846,935
    • Issue date Sep 30, 2014
    • GlaxoSmithKline LLC
    • Celine Duquenne
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Quinoline derivatives as PI3 kinase inhibitors
    • Patent number 8,785,433
    • Issue date Jul 22, 2014
    • GlaxoSmithKline LLC
    • Steven David Knight
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Imidazole-benzamide anti-cancer agents
    • Patent number 8,772,507
    • Issue date Jul 8, 2014
    • Cytokinetics, Inc.
    • Xiangping Qian
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Indoles
    • Patent number 8,765,792
    • Issue date Jul 1, 2014
    • Glaxosmithkline LLC
    • Steven David Knight
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Azaindazoles
    • Patent number 8,637,509
    • Issue date Jan 28, 2014
    • Glaxosmithkline LLC
    • Joelle Lorraine Burgess
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Quinoline derivatives as PI3 kinase inhibitors
    • Patent number 8,633,187
    • Issue date Jan 21, 2014
    • Glaxosmithkline LLC
    • Steven David Knight
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Compounds, compositions and methods
    • Patent number 8,633,236
    • Issue date Jan 21, 2014
    • Cytokinetics, Inc.
    • Andrew McDonald
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Quinoline derivatives as P13 kinase inhibitors
    • Patent number 8,404,837
    • Issue date Mar 26, 2013
    • GlaxoSmithKline LLC
    • Nicholas D. Adams
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Compounds, compositions and methods
    • Patent number 8,329,928
    • Issue date Dec 11, 2012
    • Cytokinetics, Incorporated
    • Andrew McDonald
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Imidazopyridinyl benzamide mitotic kinesin inhibitors
    • Patent number 8,207,340
    • Issue date Jun 26, 2012
    • Cytokinetics, Incorporated
    • Xiangping Qian
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Imidazopyridinyl benzamide mitotic kinesin inhibitors
    • Patent number 8,163,919
    • Issue date Apr 24, 2012
    • Cytokinetics, Incorporated
    • Xiangping Qian
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Quinoline derivatives as PI3 kinase inhibitors
    • Patent number 8,138,347
    • Issue date Mar 20, 2012
    • Glaxosmithkline LLC
    • Steven David Knight
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Compounds, compositions and methods
    • Patent number 8,119,678
    • Issue date Feb 21, 2012
    • Cytokinetics, Incorporated
    • Andrew McDonald
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds, compositions and methods
    • Patent number 7,919,524
    • Issue date Apr 5, 2011
    • Cytokinetics, Inc.
    • Andrew McDonald
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Imidazoyl-benzamide anti-cancer agents
    • Patent number 7,795,448
    • Issue date Sep 14, 2010
    • Cytokinetics, Incorporated
    • Xiangping Qian
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Compounds, compositions and methods
    • Patent number 7,629,477
    • Issue date Dec 8, 2009
    • Cytokinetics, Inc.
    • Andrew McDonald
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Imidazopyridinyl-benzamide anti-cancer agents
    • Patent number 7,618,981
    • Issue date Nov 17, 2009
    • Cytokinetics, Inc.
    • Xiangping Qian
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Imidazoyl-benzamide anti-cancer agents
    • Patent number 7,582,668
    • Issue date Sep 1, 2009
    • Cytokinetics, Incorporated
    • Xiangping Qian
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds, compositions, and methods
    • Patent number 7,528,137
    • Issue date May 5, 2009
    • Cytokinetics, Inc.
    • Bainian Feng
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
    • Publication number 20190092785
    • Publication date Mar 28, 2019
    • GlaxoSmithKline Intellectual Property (No.2) Limited
    • Steven David KNIGHT
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
    • Publication number 20180207144
    • Publication date Jul 26, 2018
    • GlaxoSmithKline LLC
    • Joelle Lorraine Burgess
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
    • Publication number 20180162845
    • Publication date Jun 14, 2018
    • GlaxoSmithKline Intellectual Property (No.2) Limited
    • James A. BRACKLEY
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
    • Publication number 20170334891
    • Publication date Nov 23, 2017
    • GlaxoSmithKline Intellectual Property (No.2) Limited
    • Steven David KNIGHT
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
    • Publication number 20170095461
    • Publication date Apr 6, 2017
    • GlaxoSmithKline LLC
    • Joelle Lorraine Burgess
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
    • Publication number 20170029412
    • Publication date Feb 2, 2017
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Charles William BLACKLEDGE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
    • Publication number 20160130261
    • Publication date May 12, 2016
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Joelle Lorraine BURGESS
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
    • Publication number 20160122342
    • Publication date May 5, 2016
    • GlaxoSmithKline Intellectual Property (No.2) Limited
    • David T. FOSBENNER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
    • Publication number 20160102083
    • Publication date Apr 14, 2016
    • GlaxoSmithKline Intellectual Property (No.2) Limited
    • Charles William BLACKLEDGE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    INDOLES
    • Publication number 20150313887
    • Publication date Nov 5, 2015
    • GlaxoSmithKline LLC
    • James BRACKLEY
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
    • Publication number 20150307480
    • Publication date Oct 29, 2015
    • GlaxoSmithKline LLC
    • Steven David KNIGHT
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
    • Publication number 20150126522
    • Publication date May 7, 2015
    • GlaxoSmithKline LLC
    • Joelle Lorraine Burgess
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    INDAZOLES
    • Publication number 20140350013
    • Publication date Nov 27, 2014
    • Celine DUQUENNE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    AZAINDAZOLES
    • Publication number 20140343056
    • Publication date Nov 20, 2014
    • GlaxoSmithKline LLC
    • Joelle Lorraine Burgess
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS
    • Publication number 20140296224
    • Publication date Oct 2, 2014
    • Nicholas D. ADAMS
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS
    • Publication number 20140100234
    • Publication date Apr 10, 2014
    • GlaxoSmithKline LLC
    • Steven David KNIGHT
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    INDOLES
    • Publication number 20130345200
    • Publication date Dec 26, 2013
    • GlaxoSmithKline LLC
    • James Brackley
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    INDOLES
    • Publication number 20130245016
    • Publication date Sep 19, 2013
    • Steven David Knight
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
    • Publication number 20130096315
    • Publication date Apr 18, 2013
    • Xiangping Qian
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    AZAINDAZOLES
    • Publication number 20130059849
    • Publication date Mar 7, 2013
    • Joelle Lorraine Burgess
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    INDOLES
    • Publication number 20130053397
    • Publication date Feb 28, 2013
    • James Brackley
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    INDAZOLES
    • Publication number 20130053383
    • Publication date Feb 28, 2013
    • GLAXOSMITHKLINE LLC
    • Celine Duquenne
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    COMPOUNDS, COMPOSITIONS AND METHODS
    • Publication number 20130053436
    • Publication date Feb 28, 2013
    • Andrew McDonald
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
    • Publication number 20120283287
    • Publication date Nov 8, 2012
    • Xiangping Qian
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    COMPOUNDS, COMPOSITIONS AND METHODS
    • Publication number 20120209012
    • Publication date Aug 16, 2012
    • Andrew McDonald
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS
    • Publication number 20120165321
    • Publication date Jun 28, 2012
    • Nicholas D. Adams
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOUNDS, COMPOSITIONS AND METHODS
    • Publication number 20110230550
    • Publication date Sep 22, 2011
    • Cytokinetics, Inc.
    • Andrew McDonald
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PYRIDOSULFONAMIDE DERIVATIVES AS P13 KINASE INHIBITORS
    • Publication number 20100311736
    • Publication date Dec 9, 2010
    • GLAXOSMITHKLINE LLC
    • Nicholas D. Adams
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    QUINOXALINE DERIVATIVES AS PI3 KINASE INHIBITORS
    • Publication number 20100234386
    • Publication date Sep 16, 2010
    • Amita Chaudhari
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS
    • Publication number 20100216801
    • Publication date Aug 26, 2010
    • Dashyant Dhanak
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE